Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kaare R. Hasløv"'
Autor:
Kasper Abildgaard Rud, Uffe B. Westergaard, Claus Nielsen, Bodil van Overeem Hansen, Gitte Stawski, Kaare R. Hasløv
Publikováno v:
Biologicals. 56:9-12
For many years in vivo assays have been a corner stone in safety testing of vaccines for human use. However, there is now an increasing regulatory focus on replacement, reduction and refinement of methods involving animal use. Accordingly, European P
Autor:
Susanne Havn Aamand, Peter Aaby, Christine Stabell Benn, Andreas Andersen, Mihai G. Netea, Kaare R. Hasløv, Sofie Biering-Sørensen, Bastiaan A. Blok, Kristoffer Jarlov Jensen, Ivan Monteiro
Publikováno v:
Vaccine, 33, 2056-65
Biering-Sørensen, S, Jensen, K J, Aamand, S H, Blok, B, Andersen, A, Monteiro, I, Netea, M G, Aaby, P, Benn, C S & Hasløv, K R 2015, ' Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial ', Vaccine, vol. 33, no. 17, pp. 2056-2065 . https://doi.org/10.1016/j.vaccine.2015.02.056
Vaccine, 33, 17, pp. 2056-65
Biering-Sørensen, S, Jensen, K J, Aamand, S H, Blok, B, Andersen, A, Monteiro, I, Netea, M G, Aaby, P, Benn, C S & Hasløv, K R 2015, ' Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial ', Vaccine, vol. 33, no. 17, pp. 2056-2065 . https://doi.org/10.1016/j.vaccine.2015.02.056
Vaccine, 33, 17, pp. 2056-65
Item does not contain fulltext INTRODUCTION: Bacille Calmette-Guerin (BCG) vaccine has beneficial non-specific effects on overall survival. After BCG vaccination, positive PPD response and scar formation are associated with increased survival. During
Publikováno v:
Biologicals. 36:308-314
An assay for quantifying viability in BCG vaccine by determining intracellular ATP content was developed and validated. ATP content was determined by measuring bioluminescence in the presence of luciferin/luciferase. During development and validation
Autor:
Marlies Halder, Susanne Berthold, Gunnar Carlin, Kaare R. Hasløv, Stefan Fennrich, Leonard Schechtman, Thomas Montag-Lessing, Martin Gommer, Albrecht Wendel, Ingeborg S. Aaberge, Emmanuelle Charton, Matthias Fischer, Stephen Poole, Gabriele Werner-Felmayer, Michael Jahnke, Thomas Hartung, Sandra Coecke
Publikováno v:
Alternatives to Laboratory Animals. 29:99-123
3Biochemical Pharmacology, University of Konstanz, P.O. Box M 655, 78457 Konstanz, Germany; 4National Institute of Public Health (NIPH), Department of Vaccinology, P.O. Box 4404 Torshov, Geitmyrsveien 75, 0403 Oslo, Norway; 5Milenia-Biotec, Hohe Stra
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 40(1)
Currently, an assay based on fatal sensitization of mice to histamine challenge is widely used for testing absence of residual pertussis toxin in acellular pertussis containing vaccines. For replacement of this lethal end-point assay, an alternative
Publikováno v:
Clinical and Vaccine Immunology, 13(9), 991-996
Clinical and Vaccine Immunology 13 (2006) 9
Clinical and Vaccine Immunology 13 (2006) 9
For over a century, purified protein derivatives (PPD) have been used to detect mycobacterial infections in humans and livestock. Among these, reagents to detect infections byMycobacterium aviumcomplex organisms have been produced, but the utility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45eb090e927c3885e03caec0c8ecaa83
https://research.wur.nl/en/publications/genetic-analysis-of-mycobacterium-avium-complex-strains-used-for-
https://research.wur.nl/en/publications/genetic-analysis-of-mycobacterium-avium-complex-strains-used-for-